Patients with COPD also have a high prevalence of CVD. Bronchodilators prescribed for symptomatic COPD control may also contribute to cardiovascular risk. In accordance with treatment guidelines, most ...

Please provide your email address to receive an email when new articles are posted on . Spirometry testing in the afternoon vs. morning was linked to a decreased likelihood for bronchodilator ...

A study of Korean patients with chronic obstructive pulmonary disease (COPD) found that a paradoxical response to short-acting bronchodilators may reduce lung function and quality of life. The study ...

Please provide your email address to receive an email when new articles are posted on . Bronchodilator responsiveness over 20% was linked to exacerbations and decreased prebronchodilator FEV 1. More ...

A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

A bronchodilator is a medication that relaxes and opens the airways, or bronchi, in the lungs. A doctor may prescribe them for asthma and other respiratory conditions. Narrowed airways make it ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

Novartis' dual combination bronchodilator Utibron Neohaler inhalation powder for patients with chronic obstructive pulmonary disease (COPD) has received FDA approval. It is not indicated to treat ...

The European Respiratory Society (ERS) and the American Thoracic Society (ATS) just published an updated technical standard on lung function interpretation. It's a critically important document ...

August 16, 2010 — Nebulized hypertonic 3% saline solution without adjunctive bronchodilators has a low rate of adverse events in infants younger than 2 years with bronchiolitis, according to the ...